-
21
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
Published 2025-01-01Subjects: Get full text
Article -
22
Development, implementation, and evaluation of an innovative clinical trial operations training program for Africa (ClinOps)
Published 2025-01-01Subjects: “…Clinical trial…”
Get full text
Article -
23
Exploring mechanisms of insulin action and strategies to treat diabetes
Published 2024-07-01Subjects: Get full text
Article -
24
Open challenges for the automatic synthesis of clinical trials
Published 2025-02-01Subjects: “…Clinical trial synthesis…”
Get full text
Article -
25
-
26
Identification of new candidate genes for the hereditary predisposition to uveal melanoma: IGCMU trial
Published 2025-01-01Subjects: Get full text
Article -
27
-
28
-
29
Assessment of Opuntia ficus-indica supplementation on enhancing antioxidant levels
Published 2025-01-01Subjects: Get full text
Article -
30
-
31
From Lab to Clinic: Effect of Academia–Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry
Published 2025-01-01Subjects: Get full text
Article -
32
Investigation on the occupational situation of clinical research associates in China
Published 2025-01-01Subjects: Get full text
Article -
33
Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
Published 2024-10-01Subjects: Get full text
Article -
34
Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
Published 2025-01-01Subjects: Get full text
Article -
35
Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial
Published 2025-01-01Subjects: Get full text
Article -
36
A new taxonomy of neuroprotective agents for stroke appropriate for the reperfusion era
Published 2025-02-01Subjects: Get full text
Article -
37
Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes
Published 2025-01-01Subjects: “…Clinical trial design…”
Get full text
Article -
38
The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate
Published 2025-01-01Subjects: “…Double-blind randomized clinical trial…”
Get full text
Article -
39
-
40